Normal and pathologic concentrations of uremic toxins

Journal of the American Society of Nephrology

Volumn 23, Issue 7, 2012, Pages 1258-1270

  Duranton, Flore ^a   Cohen, Gerald ^b   De Smet, Rita ^c   Rodriguez, Mariano ^d   Jankowski, Joachim ^e   Vanholder, Raymond ^c   Argiles, Angel ^a  

^a RD Néphrologie   (France)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; BETA 2 MICROGLOBULIN; CYSTATIN C; HOMOCYSTEINE; INDICAN; PARATHYROID HORMONE; UREMIC TOXIN; URIC ACID;

AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLUTE; SYSTEMATIC REVIEW; UREMIA;

EID: 84863528247     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011121175     Document Type: Article

References (110)

1. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003 (Pubitemid 36513344)
2. Meert N, Schepers E, De Smet R, Argiles A, Cohen G, Deppisch R, Drüeke T, Massy Z, Spasovski G, Stegmayr B, Zidek W, Jankowski J, Vanholder R: Inconsistency of reported uremic toxin concentrations. Artif Organs 31: 600-611, 2007 (Pubitemid 47101111)
3. Vanholder R, Meert N, Schepers E, Glorieux G, Argiles A, Brunet P, Cohen G, Drüeke T, Mischak H, Spasovski G, Massy Z, Jankowski J; European Uremic Toxin Work Group (EUTox): Review on uraemic solutes II-variability in reported concentrations: causes and consequences. Nephrol Dial Transplant 22: 3115-3121, 2007 (Pubitemid 350202539)
4. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE: Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21: 1041-1051, 2010
5. Aronov PA, Luo FJ-G, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW: Colonic contribution to uremic solutes. J Am Soc Nephrol 22: 1769-1776, 2011
6. Alhamdani M-SS, Al-Kassir A-HAM, Jaleel NA, Hmood AM, Ali HM: Elevated levels of alkanals, alkenals and 4-HO-alkenals in plasma of hemodialysis patients. Am J Nephrol 26: 299-303, 2006 (Pubitemid 44114401)
7. Slominska EM, Carrey EA, Foks H, Orlewska C, Wieczerzak E, Sowinski P, Yacoub MH, Marinaki AM, Simmonds HA, Smolenski RT: A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-Dribonucleoside triphosphate. J Biol Chem281: 32057-32064, 2006 (Pubitemid 46036759)
8. Goto S, Fujii H, Hamada Y, Yoshiya K, Fukagawa M: Association between indoxyl sulfate and skeletal resistance in hemodialysis patients. Ther Apher Dial 14: 417-423, 2010
9. Forlenza MJ, Miller GE: Increased serum levels of 8-hydroxy-2′- deoxyguanosine in clinical depression. Psychosom Med 68: 1-7, 2006 (Pubitemid 43803209)
10. Taes YEC, Marescau B, De Vriese A, De Deyn PP, Schepers E, Vanholder R, Delanghe JR: Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant 23: 1330-1335, 2008 (Pubitemid 351767509)
11. Derave W, Marescau B, Vanden Eede E, Eijnde BO, De Deyn PP, Hespel P: Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.JAppl Physiol 97: 852-857, 2004 (Pubitemid 39121404)
12. Tankiewicz A, Pawlak D, Pawlak K, Szewc D, Myśliwiec M, Buczko W: Anthranilic acid-uraemic toxin damaged red cell'smembrane. Int Urol Nephrol 37: 621-627, 2005 (Pubitemid 41762529)
13. Pere P, Salonen M, Jokinen M, Rosenberg PH, Neuvonen PJ, Haasio J: Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesth Analg 96: 563-569, 2003 (Pubitemid 36125783)
14. Kielstein JT, Böger RH, Bode-Böger SM, Martens-Lobenhoffer J, Lonnemann G, Frölich JC, Haller H, Fliser D: Low dialysance of asymmetric dimethylarginine (ADMA)-in vivo and in vitro evidence of significant protein binding. Clin Nephrol 62: 295-300, 2004 (Pubitemid 39386806)
15. Zhang D-L, Liu J, Liu S, Zhang Y, Liu W-H: The differences of asymmetric dimethylarginine removal by different dialysis treatments. Ren Fail 32: 935-940, 2010
16. Hasuike Y, Nakanishi T, Moriguchi R, Otaki Y, Nanami M, Hama Y, Naka M, Miyagawa K, Izumi M, Takamitsu Y: Accumulation of cyanide and thiocyanate in haemodialysis patients. Nephrol Dial Transplant 19: 1474-1479, 2004 (Pubitemid 38786741)
17. Raff AC, Lieu S, Melamed ML, Quan Z, Ponda M, Meyer TW, Hostetter TH: Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules. Am J Kidney Dis 52: 102-110, 2008 (Pubitemid 351853260)
18. Tanaka A, Takahashi Y, Mizokuchi M, Shimada N, Koide H: Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure. Ren Fail 21: 499-514, 1999 (Pubitemid 29459949)
19. De Deyn P, Marescau B, Lornoy W, Becaus I, Lowenthal A: Guanidino compounds in uraemic dialysed patients. Clin Chim Acta 157: 143-150, 1986 (Pubitemid 16084905)
20. Shahbazian H, Zand Moghadam A, Ehsanpour A, Khazaali M: Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis. Iran J Kidney Dis 3: 151-155, 2009
21. Kock R, Delvoux B, Sigmund M, Greiling H: A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases. Eur J Clin Chem Clin Biochem 32: 837-842, 1994 (Pubitemid 24359478)
22. Rutkowski P, Słominska EM, Szołkiewicz M, Aleksandrowicz E, Smolenski RT, Wołyniec W, Renke M, Wisterowicz K, Swierczynski J, Rutkowski B: Relationship between uremic toxins and oxidative stress in patients with chronic renal failure. Scand J Urol Nephrol 41: 243-248, 2007 (Pubitemid 46676354)
23. Bayés B, Pastor MC, Bonal J, Juncà J, Romero R: Homocysteine and lipid peroxidation in haemodialysis: Role of folinic acid and vitamin E. Nephrol Dial Transplant 16: 2172-2175, 2001 (Pubitemid 33062139)
24. Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H: Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 20: 1936-1943, 2005 (Pubitemid 41222611)
25. Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, Swierczynski J: N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin? Kidney Int Suppl 84: S19-S21, 2003 (Pubitemid 36513366)
26. Carrey EA, Smolenski RT, Edbury SM, Laurence A, Marinaki AM, Duley JA, Zhu L, Goldsmith DJ, Simmonds HA:Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: Positive correlation with degree of renal failure. Clin Chim Acta 335: 117-129, 2003 (Pubitemid 37338316)
27. Beerenhout CH, Luik AJ, Jeuken-Mertens SGJ, Bekers O, Menheere P, Hover L, Klaassen L, van der Sande FM, Cheriex EC, Meert N, Leunissen KM, Kooman JP: Pre-dilution on-line haemofiltration vs lowflux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 20: 1155-1163, 2005 (Pubitemid 40862105)
28. Abd-Allah NM, Hassan FH, Esmat AY, Hammad SA: Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives. Biol Res 37: 95-106, 2004 (Pubitemid 38786646)
29. Mydlík M, Derzsiová K: Oxalic Acid as a uremic toxin. J Ren Nutr 18: 33-39, 2008
30. Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F: Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 60: 74-80, 1992
31. Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 112: 256-264, 2003 (Pubitemid 38056361)
32. Kalousová M, Kielstein JT, Hodková M, Zima T, Dusilová-Sulková S, Martens-Lobenhoffer J, Bode-Boger SM: No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif 24: 439-444, 2006 (Pubitemid 46030085)
33. Bain MA, Faull R, Fornasini G, Milne RW, Evans AM: Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 21: 1300-1304, 2006
34. Taki K, Tsuruta Y, Niwa T: Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. Am J Nephrol 27: 30-35, 2007 (Pubitemid 46364538)
35. Müller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, Singh R, Farmer PB, Stockis JP, Janzowski C: Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients. Free Radic Res 38: 1093-1100, 2004 (Pubitemid 39504344)
36. De Smet R, Dhondt A, Eloot S, Galli F, Waterloos MA, Vanholder R: Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial Transplant 22: 2006-2012, 2007 (Pubitemid 47244774)
37. Sassa T, Matsuno H, Niwa M, Kozawa O, Takeda N, Niwa T, Kumada T, Uematsu T: Measurement of furancarboxylic acid, a candidate for uremic toxin, in human serum, hair, and sweat, and analysis of pharmacological actions in vitro. Arch Toxicol 73: 649-654, 2000 (Pubitemid 30117227)
38. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, Igarashi K: Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 305: 143-149, 2003 (Pubitemid 36535419)
39. Ueda S, Yamagishi S, Takeuchi M, Kohno K, Shibata R, Matsumoto Y, Kaneyuki U, Fujimura T, Hayashida A, Okuda S: Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure. Mol Med 12: 180-184, 2006 (Pubitemid 44646347)
40. Wagner Z, Molnár M, Molnár GA, Tamaskó M, Laczy B, Wagner L, Csiky B, Heidland A, Nagy J, Wittmann I: Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis 47: 294-300, 2006 (Pubitemid 43121332)
41. Sutherland WHF, Gieseg SP, Walker RJ, de Jong SA, Firth CA, Scott N: Serum protein-bound 3,4-dihydroxyphenylalanine and related products of protein oxidation and chronic hemodialysis. Ren Fail 25: 997-1009, 2003 (Pubitemid 37487091)
42. Dhondt AW, Vanholder RC, De Smet RV, Claus SA, Waterloos MA, Glorieux GL, Delanghe JR, Lameire NH: Studies on dialysate mixing in the Genius single-pass batch systemfor hemodialysis therapy. Kidney Int 63: 1540-1547, 2003 (Pubitemid 36350020)
43. Farrell PC, Gotch FA, Peters JH, Berridge BJ Jr, Lam M: Binding of hippurate in normal plasma and in uremic plasma pre- and postdialysis. Nephron 20: 40-46, 1978 (Pubitemid 8217070)
44. Perna AF, Satta E, Acanfora F, Lombardi C, Ingrosso D, De Santo NG: Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int 69: 869-876, 2006
45. Jourde-Chiche N, Dou L, Sabatier F, Calaf R, Cerini C, Robert S, Camoin-Jau L, Charpiot P, Argiles A, Dignat-George F, Brunet P: Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. J Thromb Haemost 7: 1576-1584, 2009
46. Lee C-T, Kuo C-C, Chen Y-M, Hsu CY, Lee WC, Tsai YC, Ng HY, Kuo LC, Chiou TT, Yang YK, Cheng BC, Chen JB: Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int 30: 456-463, 2010
47. Ujhelyi L, Balla G, Jeney V, Varga Z, Nagy E, Vercellotti GM, Agarwal A, Eaton JW, Balla J: Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int 69: 144-151, 2006 (Pubitemid 43117750)
48. Niwa T, Takeda N, Tatematsu A, Maeda K: Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serumas demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 34: 2264-2267, 1988 (Pubitemid 19001250)
49. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25: 1183-1191, 2010
50. Taneda S, Monnier VM: ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 40: 1766-1773, 1994 (Pubitemid 24273103)
51. Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K, Yoshida M: Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 26: 1094-1098, 2011
52. Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y: Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74: 349-355, 1996 (Pubitemid 26326708)
53. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Igarashi K: Acrolein produced from polyamines as one of the uraemic toxins. Biochem Soc Trans 31: 371-374, 2003 (Pubitemid 36520679)
54. Testa A, Gentilhomme H, Le Carrer D, Orsonneau JL: In vivo removal of high- and low-molecular-weight compounds in hemodiafiltration with on-line regeneration of ultrafiltrate. Nephron Clin Pract 104: c55-c60, 2006
55. Ekström B, Berggård I: Human alpha1-microglobulin. Purification procedure, chemical and physiochemical properties. J Biol Chem 252: 8048-8057, 1977
56. Lindström V, Grubb A, Alquist Hegbrant M, Christensson A: Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest 68: 685-691, 2008
57. Pöge U, Gerhardt TM, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP: beta-Trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem 51: 1531-1533, 2005 (Pubitemid 41060895)
58. Kim S, Oh KH, Chin HJ, Na KY, Kim YS, Chae DW, Ahn C, Han JS, Kim S, Joo KW: Effective removal of leptin via hemodiafiltration with online endogenous reinfusion therapy. Clin Nephrol 72: 442-448, 2009
59. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D: Adiponectin in chronic kidney disease is relatedmore to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20: 129-134, 2005 (Pubitemid 40207617)
60. Ouseph R, Hutchison CA, Ward RA: Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers. Nephrol Dial Transplant 23: 1704-1712, 2008 (Pubitemid 351767771)
61. Shapiro R, Strydom DJ, Olson KA, Vallee BL: Isolation of angiogenin from normal human plasma. Biochemistry 26: 5141-5146, 1987 (Pubitemid 17134821)
62. d'Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL; French Group GTE (Groupe des Tumeurs Endocrines): Reference range of serum calcitonin levels in humans: Influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157: 749-755, 2007
63. Pascual M, Steiger G, Estreicher J, Macon K, Volanakis JE, Schifferli JA:Metabolismof complement factor D in renal failure. Kidney Int 34: 529-536, 1988
64. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T: Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 33: 944-952, 2010
65. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, van Ypersele de Strihou C, Bernard A: Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 45: 1689-1696, 1994 (Pubitemid 24207505)
66. Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M: Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44: 250-256, 2004 (Pubitemid 38962552)
67. Yu M, Kim YJ, Kang D-H: Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6: 30-39, 2011
68. Friedrich N, Alte D, Völzke H, Spilcke-Liss E, Lüdemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H: Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: Results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res 18: 228-237, 2008 (Pubitemid 351479927)
69. Rysz J, BanachM, Cialkowska-Rysz A, Stolarek R, Barylski M, Drozdz J, Okonski P: Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol 3: 151-154, 2006
70. Stinghen AE, Gonçalves SM, Martines EG, Nakao LS, Riella MC, Aita CA, Pecoits-Filho R: Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 111: c117-c126, 2009
71. Berrahmoune H, Lamont JV, Herbeth B, Fitz Gerald PS, Visvikis-Siest S: Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort. Clin Chem 52: 504-510, 2006
72. Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas F: Interleukin-10 levels are often elevated in serumof adultswith Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol 10: 433-440, 1999 (Pubitemid 29236421)
73. Ottonello L, Gnerre P, Bertolotto M, Mancini M, Dapino P, Russo R, Garibotto G, Barreca T, Dallegri F: Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol 15: 2366-2372, 2004 (Pubitemid 39159336)
74. Dagogo-Jack S, Ovalle F, Landt M, Gearing B, Coyne DW: Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 18: 34-40, 1998 (Pubitemid 28184885)
75. Chen IW, David R, Maxon HR, Sperling M, Stein EA: Age-, sex-, and race-related differences in myoglobin concentrations in the serum of healthy persons. Clin Chem 26: 1864-1868, 1980 (Pubitemid 11205480)
76. Kusec V, Lukić M, Stavljenić-Rukavina A: Osteocalcin reference range in a Croatian population sample. Acta Med Croatica 48: 59-62, 1994
77. Scholze A, Jankowski V, Henning L, Haass W, Wittstock A, Suvd-Erdene S, Zidek W, Tepel M, Jankowski J: Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy. Nephron Clin Pract 107: c1-c6, 2007 (Pubitemid 47360944)
78. Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y: Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism. Am J Kidney Dis 35: 458-464, 2000
79. Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP: Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: Evaluation and validation on common immunoassay platforms. Clin Chem 54: 1673-1681, 2008
80. Hung C-Y, Chen Y-L, Chen C-S, Yang C-S, Peng S-J: Association of leptin with hemodialysis-related muscle cramps: A cross-sectional study. Blood Purif 27: 159-164, 2009
81. Ficheux A, Gayrard N, Szwarc I, Andress D, Soullier S, Duny Y, Goubert G, Thomas M, Bismuth-Mondolfo J, Daurès JP, Brunet P, Servel MF, Argilés A: The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis. Nephrol Dial Transplant 26: 2281-2289, 2011
82. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr, Ballantyne CM: Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93: 1334-1338, 1996 (Pubitemid 26099343)
83. Nolin TD, Appiah K, Kendrick SA, Le P, McMonagle E, Himmelfarb J: Hemodialysis acutely improves hepatic CYP3A4 metabolic activity. J Am Soc Nephrol 17: 2363-2367, 2006 (Pubitemid 44300952)
84. Terrier-Lenglet A, Nollet A, Liabeuf S, Barreto DV, Brazier M, Lemke HD, Vanholder R, Choukroun G, Massy ZA; Groupe EUTox (European Uremic toxin): Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease. Nephrol Ther 7: 219-224, 2011
85. Splendiani G, De Angelis S, Tullio T, Ferranini M, Dessì MR, Pastore A, Casciani S, Liberatoscioli L, Federici G, Cortese C: Selective adsorption of homocysteine using an HFR-ON LINE technique. Artif Organs 28: 592-595, 2004 (Pubitemid 38692272)
86. Chen ZJ, Cao G, Tang WX, Lv XY, Huang SM, Qin W, Ping F, Ye T: A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis inthe treatmentof uraemic pruritus. Clin Exp Dermatol 34: 679-683, 2009
87. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
88. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69: 1081-1087, 2006 (Pubitemid 43372184)
89. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predictmortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol 17: 546-555, 2006
90. Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Cohen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R; European Uremic Toxin Work Group (EUTox): Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif 30: 277-287, 2010
91. Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ: Cardiovascularmorbidity andmortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J AmColl Cardiol 47: 1108-1116, 2006
92. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R; Membrane Permeability Outcome (MPO) Study Group: Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20: 645-654, 2009
93. Jankowski V, Tölle M, Vanholder R, Schönfelder G, van der Giet M, Henning L, Schlüter H, Paul M, Zidek W, Jankowski J: Uridine adenosine tetraphosphate: A novel endothelium-derived vasoconstrictive factor. Nat Med 11: 223-227, 2005 (Pubitemid 40321359)
94. Schuchardt M, Tölle M, Prüfer J, Prüfer N, Huang T, Jankowski V, Jankowski J, Zidek W, van der Giet M: Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int 81: 256-265, 2012
95. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 64: 305-313, 2003 (Pubitemid 36714185)
96. Capeillère-Blandin C, Gausson V, Nguyen AT, Descamps-Latscha B, Drüeke T, Witko-Sarsat V: Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 21: 1555-1563, 2006 (Pubitemid 43840618)
97. Lim WH, Kireta S, Leedham E, Russ GR, Coates PT: Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 72: 1138-1148, 2007 (Pubitemid 47609031)
98. Schrijvers BF, Flyvbjerg A, De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65: 2003-2017, 2004 (Pubitemid 38669987)
99. Suliman ME, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P: Soluble adhesionmolecules in end-stage renal disease: A predictor of outcome. Nephrol Dial Transplant 21: 1603-1610, 2006 (Pubitemid 43834642)
100. Moon SJ, Kim DK, Chang JH, Kim CH, Kim HW, Park SY, Han SH, Lee JE, Yoo TH, Han DS, Kang SW: The impact of dialysismodality on skin hyperpigmentation in haemodialysis patients. Nephrol Dial Transplant 24: 2803-2809, 2009
101. Brandenburg VM, Schlieper G, Heussen N, Holzmann S, Busch B, Evenepoel P, Vanholder R, Meijers B, Meert N, Fassbender WJ, Floege J, Jahnen-Dechent W, Ketteler M: Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: A prospective study. Nephrol Dial Transplant 25: 2672-2679, 2010
102. Campo A, Lanfranco G, Gramaglia L, Goia F, Cottino R, Giusto V: Could plasma cystatin C be useful as a marker of hemodialysis low molecular weight proteins removal? Nephron Clin Pract 98: c79-c82, 2004 (Pubitemid 39482569)
103. Cohen G, Rudnicki M, Schmaldienst S, Hörl WH: Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. Nephrol Dial Transplant 17: 879-883, 2002
104. de Loor H, Bammens B, Evenepoel P, De Preter V, Verbeke K: Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem 51: 1535-1538, 2005
105. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16: 3430-3436, 2005 (Pubitemid 46187553)
106. Vanholder R, Bammens B, de Loor H, Glorieux G, Meijers B, Schepers E, Massy Z, Evenepoel P: Warning: The unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant 26: 1464-1467, 2011
107. Kerr PB, Argilés A, Flavier JL, Canaud B, Mion CM: Comparison of hemodialysis and hemodiafiltration: A long-term longitudinal study. Kidney Int 41: 1035-1040, 1992
108. Horowitz JD, Heresztyn T: An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations. J Chromatogr B Analyt Technol Biomed Life Sci 851: 42-50, 2007 (Pubitemid 46720137)
109. Meert N, Waterloos M-A, Van Landschoot M, Dhondt A, Ledebo I, Glorieux G, Goeman J, Van der Eycken J, Vanholder R: Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 34: 580-585, 2010
110. Tukey JW: Exploratory Data Analysis, Reading, MA, Addison-Wesley, 1977